首页> 美国卫生研究院文献>other >Development of Multiplexed Real-Time Quantitative PCR Assay for Detecting Human Adenoviruses
【2h】

Development of Multiplexed Real-Time Quantitative PCR Assay for Detecting Human Adenoviruses

机译:检测人腺病毒的多重实时定量PCR分析方法的建立

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Adenoviruses (AdV) have been associated with a wide variety of human disease and are increasingly recognized as viral pathogens that can cause significant morbidity and mortality in immunocompromised patients. Early detection of AdV DNA in plasma and sterile fluids has been shown to be useful for identifying patients at risk for invasive AdV disease. Due to the large number of existing Adv types, few real-time quantitative AdV PCR assays published effectively cover all AdV types. We designed a series of AdV PCR primers and probes and empirically multiplexed them into two separate real-time PCR assays to quantitatively detect all 49 serotypes of human AdV (Types 1-49) available from ATCC. We then subsequently multiplexed all the primers and probes into one reaction. The sensitivity of these assays was determined to be less than 10 copies per reaction (500 copies/ml plasma). In a retrospective evaluation we detected all 84 clinical AdV isolates isolated in cell culture from patients undergoing hematopoietic stem cell transplant (HSCT) between 1981 and 1987. Prospective analysis of 46 consecutive clinical samples submitted for adenovirus testing showed greater sensitivity and equal specificity of the AdV PCR than viral culture. This real time PCR assay allows rapid, sensitive and specific quantification of all currently defined adenoviruses into either two or one multiplex assay for clinical samples.
机译:腺病毒(AdV)已与多种人类疾病相关联,并日益被公认为是病毒病原体,可在免疫功能低下的患者中引起明显的发病率和死亡率。血浆和无菌液中AdV DNA的早期检测已被证明可用于识别有感染性AdV疾病风险的患者。由于现有的Adv类型数量众多,因此发布的实时定量AdV PCR分析很少能有效涵盖所有AdV类型。我们设计了一系列AdV PCR引物和探针,并根据经验将它们复用到两个单独的实时PCR分析中,以定量检测可从ATCC获得的49种人类AdV血清型(1-49型)。然后,我们随后将所有引物和探针多路复用到一个反应中。这些测定的灵敏度确定为每个反应小于10份(500份/毫升血浆)。在一项回顾性评估中,我们检测了1981年至1987年间从造血干细胞移植(HSCT)患者的细胞培养物中分离出的所有84种临床AdV分离株。对46份连续进行腺病毒检测的临床样品的前瞻性分析显示,AdV具有更高的敏感性和同等特异性PCR比病毒培养。这种实时PCR检测可将所有当前定义的腺病毒快速,灵敏和特异地定量化为两种或一种用于临床样品的多重检测。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号